Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lidocaine 400mg/20ml (2%) solution for injection vials
1502010J0AAAHAH
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 329 |
|
Lidocaine 36mg/Adrenaline (base) 22.5microg/1.8ml inj cart
1502010J0AAENEN
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 272 |
|
Alfentanil 5mg/1ml solution for injection ampoules
1501043A0AAADAD
|
Alfentanil hydrochloride | Alfentanil hydrochloride | Anaesthesia | 253 |
|
Lidocaine 2% gel
1502010J0AAEPEP
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 232 |
|
Lidocaine 200mg/10ml (2%) solution for injection ampoules
1502010J0AACECE
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 207 |
|
Lidocaine 50mg/10ml (0.5%) solution for injection ampoules
1502010J0AACFCF
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 207 |
|
Lidocaine 50mg/5ml (1%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAKBD
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 193 |
|
Lidocaine 100mg/10ml (1%) inj Mini-Plasco ampoules (B.Braun)
1502010J0BNAFBW
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 146 |
|
Xylocaine 2% with Adrenaline 1 in 80,000 Dental inj 2.2ml
1502010J0BBBKCQ
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 142 |
|
Hypnovel 10mg/2ml solution for injection ampoules
1501041T0BBABAA
|
Hypnovel | Midazolam hydrochloride | Anaesthesia | 125 |
|
Rexocaine 2% injection 2.2ml cartridges
1502010J0BQAACQ
|
Rexocaine | Lidocaine hydrochloride | Anaesthesia | 121 |
|
Denela 5% cream
1502010J0BUAABY
|
Denela | Lidocaine hydrochloride | Anaesthesia | 118 |
|
Mepivacaine 66mg/2.2ml solution for injection cartridges
1502010ABAAABAB
|
Mepivacaine hydrochloride | Mepivacaine hydrochloride | Anaesthesia | 105 |
|
Lidocaine 100mg/5ml (2%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAICB
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 97 |
|
Midazolam 5mg/ml oral solution sugar free
1501041T0AAAVAV
|
Midazolam hydrochloride | Midazolam hydrochloride | Anaesthesia | 82 |
|
Bupivacaine 0.25% inj 10ml Sure-Amp ampoules
1502010C0BCABAB
|
Sure-Amp Bupivacaine hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 74 |
|
Lidocaine 5% / Phenylephrine 0.5% nasal spray
1502010J0AADTDT
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 65 |
|
Alfentanil 5mg/10ml solution for injection ampoules
1501043A0AAACAC
|
Alfentanil hydrochloride | Alfentanil hydrochloride | Anaesthesia | 64 |
|
Parecoxib 40mg inj vials
1501042H0AAAAAA
|
Parecoxib sodium | Parecoxib sodium | Anaesthesia | 62 |
|
Citanest 3% with Octapressin Dental 1.19microg/2.2ml inj
1502010S0BBAKAK
|
Citanest | Prilocaine hydrochloride | Anaesthesia | 55 |
|
Lidocaine 200mg/10ml (2%) inj Mini-Plasco ampoules
1502010J0BNAACE
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 50 |
|
Lidocaine 100mg/10ml (1%) inj Mini-Plasco ampoules (Hameln)
1502010J0BNAJBW
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | 48 |
|
Parecoxib 40mg powder for solution for injection vials
1501042H0AAABAB
|
Parecoxib sodium | Parecoxib sodium | Anaesthesia | 44 |
|
Ketorolac 30mg/1ml solution for injection ampoules
1501042E0AAAAAA
|
Ketorolac trometamol (Systemic) | Ketorolac trometamol | Anaesthesia | 36 |
|
Citanest 3% with Octapressin Dental 0.066units/2.2ml inj
1502010S0BBAJAJ
|
Citanest | Prilocaine hydrochloride | Anaesthesia | 35 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.